Recent Updates
Recently added Catalysts

Assertio Holdings, Inc.

ASRT
UndervaluedPharma · Commercial
FDA catalysts, PDUFA dates & pipeline intelligence
$23.5
▲ 0 · 0%

Last traded Jun 15, 2026. This price is not current.

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full ASRT financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $8.6152W HIGH $23.46
Volume
274.34 K
Value Traded
2.97 M
Short % Float
2.51%
+0.56%Week
+29.29%1 Month
+95.33%3 Month
+117.04%6 Month
+4.88%5 Year
-90.23%All Time

Cash Data

Unlock ASRT cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
151.54 M
EPS (TTM)
-5.56
P/E Ratio
-4.22
Ent. Value
120.28 M
Total Shares
6.42 M
Float Shares
6.23 M
Insiders
0.13%
Institutions
28.42%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
PDUFA
2026
Example Drug
Treatment for example condition requiring FDA review
Phase 3Small MoleculeOncology-
Unlock every ASRT catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

ASRT Catalyst Timeline

Dated clinical, regulatory and corporate events for Assertio Holdings, Inc.

Unlock the full ASRT catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How ASRT actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
2022-09-09Rolvedon (eflapegrastim-xnst) PDUFA Date ApprovedPDUFA
Unlock 14 more ASRT historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

C50 / 100
Pipeline Score
$554M
Pipeline Value
$102M
Commercial Value
Undervalued
Valuation Signal
5
Drugs Scored
11.2x
rNPV / MCap
Assertio Holdings, Inc. carries a moderate pipeline score (50/100), with $2.2B risk-adjusted pipeline value, led by Ozarelix in Prostate Cancer (Phase 2), across $74B in total addressable markets.
Commercial products (revenue basis: trailing 4 quarters of total revenue (10-K and 10-Q), to Mar 2026; product lines: last four quarters to Mar 2026 (10-K and 10-Q)) Revenue $102.2M x 1.0 = $102M
ProductRevenuePrior periodChange
ROLVEDON$56M$59M-5.3%
INDOCIN products$17M$24M-28.9%
Sympazan$12M$10M+17.3%
SPRIX$8M$8M-0.6%
Showing 1 of 5 assets
DrugIndicationPhasePTRSrNPVStatusEnrollVelocityDesignEst. CompletionML SignalLast Change
Ozarelix Small moleculeCompletedNCT01252693Prostate CancerPhase 2 COMPLETED 203May 1, 2015
Unlock the ASRT pipeline intelligence model
Every scored asset with PTRS, rNPV, enrollment velocity and trial design quality.
Institutional-grade data · Cancel anytime

Clinical Trial Results

Readouts, endpoints and source filings for every ASRT program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Example Drug Example indication for clinical evaluationPhase 32025-12-01The study met its primary endpoint demonstrating statistically significant improvement.Read MorePhase 3 Study Results AnnouncementRead More
Scroll for more · summaries link to the source press release
Unlock every ASRT trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock ASRT insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Mason Heather LDirectorDisposition -6,666 20,944 held$0.00 05/13/2026
Unlock the full ASRT insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Hedge Funds invested in ASRT

Fund % of Portfolio Current MV Shares Owned Activity
Opaleye Management Inc. 0.7 % (133.3 %) 5.06 M 265.71 K -6.77% ( -19.29 K)
Unlock every fund holding ASRT
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in ASRT
Shares held by hedge funds each quarter, and who bought or sold.

ASRT Institutional Ownership Trends

Options Data

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
Unlock ASRT option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live ASRT option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock ASRT options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How ASRT ranks across every disease it competes in

Competitive Position is a premium feature
See how ASRT ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

ASRT News

About Assertio Holdings, Inc.

Lake Forest, IL 53 employees assertiotx.com
Headquarters100 S. SAUNDERS ROAD, LAKE FOREST, IL, 60045
Founded1995
BIOPHARMAWATCH ELITE PLUS
Trade the next ASRT catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime